Clinical Trials Directory

Trials / Completed

CompletedNCT05452863

O2matic Cardiology Protocol

Automatic Oxygen Supply With the O2matic Device for the Treatment of Hospitalized Heart Patients With Hypoxia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hvidovre University Hospital · Academic / Other
Sex
All
Age
30 Years
Healthy volunteers
Not accepted

Summary

Automatic oxygen supply with the O2matic device has been shown to provided an enhanced oxygen treatment in patients with hypoxemia. O2matic was significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia in patients suffering from chronic obstructive pulmonary disease. This trial investigates the effect of using O2matic in hypoxic patients submitted to the Department of Cardiology.

Detailed description

Oxygen supply to patients with cardiovascular disease has been subject to several investigations. Both too much and too little oxygen is supposed to be harmful. The O2matic device is a new way of supplying oxygen treatment which is significantly better than manual control to maintain oxygen saturation within target interval and to reduce time with unintended hypoxemia. The device has past favorable tests in patients suffering from chronic obstructive pulmonary disease. This study investigates the application of the O2matic device on hypoxic patients admitted to the Cardiology ward.

Conditions

Interventions

TypeNameDescription
DEVICEO2matic administered oxygenOxygen supply is adjusted from an almost continuous measurement of the oxygen saturation with an appropriate an previously tested algorithm.
DEVICEManual oxygen supply and adjustmentsOxygen supply is adjusted from manual measurements of the oxygen saturation

Timeline

Start date
2022-03-01
Primary completion
2023-03-18
Completion
2024-03-18
First posted
2022-07-11
Last updated
2024-09-19

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05452863. Inclusion in this directory is not an endorsement.